Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Receivables - Doubtful (2012 - 2018)

Updated

Ernexa Therapeutics (ERNA) recorded Receivables - Doubtful of $361,000 in Q3 2018.

Analysis

Ernexa Therapeutics (ERNA) Receivables - Doubtful (2012 - 2018) Analysis & Trends

At the end of FY2017, Ernexa Therapeutics reported Receivables - Doubtful of $463,000, up 23.1% from FY2016.

  • Annual Receivables - Doubtful has a five-year compound annual growth rate of 15.4% (FY2012 to FY2017).
  • Across earlier years, Receivables - Doubtful came in at $376,000 in FY2016 and $184,000 in FY2013 (-18.6%).
  • The Q3 2018 figure is the lowest quarterly Receivables - Doubtful since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Doubtful (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 361,000.00
Dec 31, 2017 463,000.00
Dec 31, 2016 376,000.00
Jun 30, 2014 300,000.00
Dec 31, 2013 184,000.00
Sep 30, 2013 134,000.00
Dec 31, 2012 226,000.00
API Access

Ernexa Therapeutics Receivables - Doubtful API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-doubtful&ticker=ERNA&period=max&api_key=YOUR_API_KEY